Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 3,756 | 4,201 | 1,951 | 3,466 | 0 |
| Gross Profit | 3,756 | 4,201 | 1,951 | 3,466 | N/A |
| Operating Expenses | 17,842 | 16,759 | 15,270 | 16,145 | 0 |
| Operating Income | -14,086 | -12,558 | -13,319 | -12,679 | N/A |
| Interest Expense | 505 | 293 | 196 | 208 | 0 |
| Other Income | -598 | -343 | 25 | 152 | 0 |
| Pre-tax Income | -15,189 | -13,194 | -13,490 | -12,735 | 0 |
| Net Income Continuous | -15,189 | -13,194 | -13,490 | -12,735 | N/A |
| Net Income | $-15,189 | $-13,194 | $-13,490 | $-12,735 | $N/A |
| EPS Basic Total Ops | 0.13 | -32.12 | -33.03 | -33.16 | N/A |
| EPS Basic Continuous Ops | 0.12 | -32.14 | -32.97 | -33.22 | N/A |
| EPS Diluted Total Ops | 0.13 | -32.12 | -33.03 | -33.16 | N/A |
| EPS Diluted Continuous Ops | 0.12 | -32.14 | -32.97 | -33.22 | N/A |
| EBITDA(a) | $-13,860 | $-12,340 | $-13,111 | $-12,477 | $N/A |